Swedencare AB (publ) INTERIM REPORT January 1...

Swedencare AB (publ) has released its interim report for the first quarter of 2026, highlighting a net revenue of 650.3 million SEK, reflecting a modest year-over-year increase of 1%. The report indicates that organic growth reached 11%, which is a notable improvement compared to the previous year's first quarter. However, the overall financial performance was impacted by a stronger Swedish krona, which has affected revenue figures. The operational EBITDA rose by 3% to 127.7 million SEK, resulting in an EBITDA margin of 19.6%. Despite these positive indicators, profit after tax decreased to 17.7 million SEK from 23.9 million SEK in the same quarter last year, and earnings per share fell to 0.11 SEK from 0.15 SEK.

When examining this announcement in the context of Swedencare's previous disclosures, it is evident that while the company has achieved double-digit organic growth for the third consecutive quarter, the overall revenue growth has slowed compared to prior periods. In the previous quarter, the company reported a stronger performance, and the current figures suggest a potential stagnation in revenue growth due to external factors such as currency fluctuations. The CEO's comments regarding the stable underlying demand and the transition of NaturVet's Amazon sales indicate that the company is aware of the challenges it faces, particularly in maintaining profitability amid these changes. The expectation of normalization in margins by the second half of the year is a critical point to monitor, as it suggests that the company is actively working to address these issues.

Financially, Swedencare's cash flow from operating activities was reported at 65.3 million SEK, which is a decrease from 96.7 million SEK in the previous year. This decline raises questions about the company's ability to sustain its operational activities without further capital raises. The cash reserves at the end of the quarter stood at 94.9 million SEK, down significantly from 526.9 million SEK a year earlier. This substantial reduction in cash reserves indicates a potential funding gap that could impact future growth initiatives. The net debt to operational EBITDA ratio has increased to 2.8, up from 2.0, which further underscores the company's need to manage its debt levels carefully.

In terms of valuation, Swedencare's performance can be compared to peers in the pet healthcare sector. Companies such as PetMed Express Inc (NASDAQ:PETS) and Zoetis Inc (NYSE:ZTS) provide a relevant backdrop for analysis. PetMed Express, for instance, has a market capitalization of approximately 300 million USD and reported a revenue growth of 10% in its latest quarter, indicating a competitive position in the market. Zoetis, a larger player with a market cap exceeding 70 billion USD, has consistently demonstrated strong revenue growth and profitability, which sets a high benchmark for Swedencare. The current valuation metrics suggest that while Swedencare is achieving organic growth, it may not be sufficient to justify its market position compared to these larger peers, especially given the recent declines in profit and cash reserves.

The announcement also highlights a significant red flag regarding the company's reliance on Amazon sales, particularly for its NaturVet brand. The transition of these sales has been cited as a factor affecting margins, and the CEO's comments suggest that this issue is not fully resolved. The company's strategy to reactivate proven marketing programs for NaturVet on Amazon is a positive step, but it raises concerns about the effectiveness of its current sales strategy and the potential for ongoing margin pressures in the near term. Additionally, the cautious behavior observed in the U.S. veterinary market, as noted in the report, could further complicate Swedencare's growth trajectory.

Looking ahead, Swedencare has scheduled a Capital Markets Day on June 2, 2026, in Stockholm, which is expected to provide further insights into the company's strategic direction and operational plans. This event will be crucial for investors to gauge management's confidence in overcoming current challenges and achieving its long-term growth targets.

In conclusion, while Swedencare AB (publ) has reported some positive growth figures, the overall context of the interim report reveals a more complex picture. The decline in profit after tax, reduced cash reserves, and increased net debt present significant challenges that could impact the company's future performance. The announcement can be classified as moderate, as it reflects ongoing growth but also highlights critical areas of concern that investors should closely monitor. The headline sentiment of organic growth is somewhat warranted, but the underlying financial pressures and market conditions suggest a need for caution moving forward.

Key insights

• ●Profit after tax decreased to 17.7 MSEK from 23.9 MSEK year-over-year.
• ●Cash reserves fell significantly to 94.9 MSEK from 526.9 MSEK.
• ●Organic growth of 11% is positive but overshadowed by margin pressures.

Disagree with this article?